Merrimack Reports First Quarter 2019 Financial Results

Friday, May 10, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Merrimack Pharmaceuticals, Inc.

Selected Balance Sheet Data (unaudited)

(in thousands)

March 31, 2019

December 31, 2018

Cash, cash equivalents and marketable securities

$                    58,466

$                    71,278

Working capital

51,880

61,307

Total assets

74,353

88,543

Total liabilities

25,389

29,724

Total stockholders' equity

48,964

58,819



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store